| abstract |
The present invention relates to cyclic iminopyrimidine compounds and their bicyclic derivatives, pharmaceutical compositions comprising such compounds, and methods of using such compounds or compositions, including methods of treating a proliferation disorder, such as cancer or tumor, or in some embodiments, disease or disorders associated with kinase dysregulation, including, but not limited to, B-Raf V600E kinase. |